Live news related to ABIVAX stock (FR0012333284): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Abivax announces nine scientific abstracts concerning obebazimod at the Digestive Disease Week, scheduled from May 2 to May 5, 2026, in Chicago. These…
Abivax announces the presentation of nine scientific abstracts focused on obefazimod at the Digestive Disease Week conference, scheduled from May 2 to…
The stock of French biotech company Abivax significantly dropped this Monday, April 13, falling to 102.40 euros after closing at 107.90 euros on Frida…
Abivax climbs 3.41% this Friday to €109.10, driven by a spectacular increase in the price target set by Oddo BHF the previous day. The French biotech …
The French biotech company's stock increased by 2.77% this Thursday to €103.80, in a declining Paris market. This rise occurs as the CAC 40 drops by 0…
On Wednesday, April 8, the stock of the French biotech company Abivax significantly advanced in a buoyant Parisian market. Abivax traded around €103.1…
The stock of the French biotech company significantly lost ground this Thursday, in a pressured Parisian market. Abivax fell by 4.41% to €97.50, dropp…
The stock of French biotech company Abivax saw a significant increase this Wednesday, climbing 4.49% to €97.80 during the session. This rebound comes …
French biotech company Abivax has announced its 2025 results, highlighted by a fundraising of EUR 597.2 million in July, boosting its cash reserves to…
Abivax shares fell 3.84% to €105.20 at midday this Monday, as the French biotech company released its annual results for 2025. The decline occurred du…
